Home/Filings/4/0001209191-09-051132
4//SEC Filing

McDonough Mark E 4

Accession 0001209191-09-051132

CIK 0000064978other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 9:41 PM ET

Size

42.5 KB

Accession

0001209191-09-051132

Insider Transaction Report

Form 4
Period: 2009-11-03
McDonough Mark E
Vice President and Treasurer
Transactions
  • Other

    Common Stock - 401(k) plan

    2009-10-292,353.8950 total(indirect: By 401(k))
  • Disposition to Issuer

    RSU - Leader Shares

    2009-11-031,3000 total
    From: 2010-03-02Exp: 2010-03-02Common Stock (1,300 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-031,0550 total
    Exercise: $45.98From: 2003-08-01Exp: 2012-07-31Common Stock (1,055 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-035,2500 total
    Exercise: $48.24From: 2005-02-27Exp: 2014-02-26Common Stock (5,250 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-0311,2000 total
    Exercise: $23.45From: 2010-04-24Exp: 2019-04-23Common Stock (11,200 underlying)
  • Disposition to Issuer

    Common Stock

    2009-10-293,138.8610 total
  • Disposition to Issuer

    Restricted Stock Unit

    2009-11-031,5000 total
    From: 2011-02-28Exp: 2011-02-28Common Stock (1,500 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2009-11-032,1000 total
    From: 2012-04-24Exp: 2012-04-24Common Stock (2,100 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2009-11-034,6250 total
    From: 2012-10-27Exp: 2012-10-27Common Stock (4,625 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-034,7470 total
    Exercise: $62.09From: 2005-02-22Exp: 2010-02-21Common Stock (4,747 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-036,3750 total
    Exercise: $31.84From: 2006-02-25Exp: 2015-02-24Common Stock (6,375 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-031,5820 total
    Exercise: $64.35From: 2006-08-01Exp: 2011-07-31Common Stock (1,582 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-038,4000 total
    Exercise: $35.09From: 2007-03-03Exp: 2016-03-02Common Stock (8,400 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-0310,5000 total
    Exercise: $44.19From: 2008-03-02Exp: 2017-03-01Common Stock (10,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-036,8570 total
    Exercise: $58.91From: 2003-03-01Exp: 2012-02-29Common Stock (6,857 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-037,0680 total
    Exercise: $49.96From: 2004-02-28Exp: 2013-02-27Common Stock (7,068 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-034,7470 total
    Exercise: $75.76From: 2006-03-02Exp: 2011-03-01Common Stock (4,747 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-038,0000 total
    Exercise: $44.30From: 2009-02-28Exp: 2018-02-28Common Stock (8,000 underlying)
Footnotes (5)
  • [F1]Disposed of upon the completion of and pursuant to the transactions contemplated by the Agreement and Plan of Merger with, inter alia, Schering-Plough Corporation (the "Transactions") under which Schering-Plough Corporation (renamed as Merck & Co., Inc.) survives (the "Surviving Corporation") and becomes the sole shareholder of Merck & Co., Inc. (renamed Merck Sharp & Dohme Corp.) ("Old Merck"). Such shares of Old Merck common stock are being exchanged pursuant to the Transactions for an equilavent amount of whole and fractional shares of Surviving Corporation common stock. On the effective date of the Transactions, the closing price of Old Merck common stock was $30.67 per share and the closing price of Schering-Plough Corporation common stock was $28.15 per share.
  • [F2]Shares of Old Merck common stock acquired under the 401(k) plan will be exchanged for an equivalent number of shares of Surviving Corporation common stock as part of the Transaction.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Old Merck common stock and was (i) assumed by the Surviving Corporation in the Transactions and (ii) converted into a restricted stock unit representing a contingent right to receive on share of Surviving Corporation Common Stock on the same vesting schedule as applied prior to the Transactions.
  • [F4]This option to purchase shares of Old Merck common stock, which vesting in three equal annual installments beginning one year from date of grant, was assumed by Surviving Corporation in the Transactions and continued on the same terms and conditions as an option to purchase an equivalent number of shares of Surviving Corporation Common Stock at the same exercise price as applied prior to the Transactions.
  • [F5]This option to purchase shares of Old Merck common stock, which vesting on the exercisable date, was assumed by the Surviving Corporation in the Transactions and continued on the same terms and conditions as an option to purchase an equivalent number of shares of Surviving Corporation Common Stock at the same exercise price as applied prior to the Transactions.

Issuer

MERCK SHARP & DOHME CORP.

CIK 0000064978

Entity typeother

Related Parties

1
  • filerCIK 0001388793

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 9:41 PM ET
Size
42.5 KB